Some very interesting research has just landed from the American College of Surgeons published in their journal.
The graphic below distills the basic research findings.
RYGB : Roux-en-Y gastric bypass
SG: Sleeve Gastrectomy
To quote the original article:
"T2DM remission rates after RYGB are maintained despite WR, arguing for a concurrent weight-loss independent metabolic benefit likely facilitated by bypassing the proximal small-intestine."
The original research article can be found here.
*All information is general in nature, patients should consider their own personal circumstances and seek a second opinion. Any surgical or invasive procedure carries risks
Medications will be assessed pre-operatively and post-operatively. With weight-loss and particularly after surgery, comorbidities can change for the better, particularly e.g., hypertension or diabetes. It is essential for your health that medications are discussed with you, your GP and/or any other specialists such as Cardiologist or Endocrinologist etc.
In addition, use of multivitamins, and alternative supplements should be discussed with the practice to promote your better health.
"Expert care - excellent results"